Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, September 18, 2017
[ Mon, Sep 18th 2017
] - WOPRAI
[ Mon, Sep 18th 2017
] - WOPRAI
[ Mon, Sep 18th 2017
] - WOPRAI
[ Mon, Sep 18th 2017
] - WOPRAI
Fri, September 15, 2017
[ Fri, Sep 15th 2017
] - WOPRAI
[ Fri, Sep 15th 2017
] - WOPRAI
[ Fri, Sep 15th 2017
] - WOPRAI
[ Fri, Sep 15th 2017
] - WOPRAI
[ Fri, Sep 15th 2017
] - WOPRAI
[ Fri, Sep 15th 2017
] - WOPRAI
[ Fri, Sep 15th 2017
] - WOPRAI
[ Fri, Sep 15th 2017
] - WOPRAI
[ Fri, Sep 15th 2017
] - WOPRAI
[ Fri, Sep 15th 2017
] - WOPRAI
[ Fri, Sep 15th 2017
] - WOPRAI
[ Fri, Sep 15th 2017
] - WOPRAI
[ Fri, Sep 15th 2017
] - WOPRAI
[ Fri, Sep 15th 2017
] - WOPRAI
[ Fri, Sep 15th 2017
] - WOPRAI
[ Fri, Sep 15th 2017
] - WOPRAI
[ Fri, Sep 15th 2017
] - WOPRAI
[ Fri, Sep 15th 2017
] - WOPRAI
Christopher Marai Initiated (ALNY) at Sell and Held Target at $56 on, Sep 15th, 2017
Christopher Marai of Nomura, Initiated "Alnylam Pharmaceuticals, Inc." (ALNY) at Sell and Held Target at $56 on, Sep 15th, 2017.
Christopher has made no other calls on ALNY in the last 4 months.
There are 3 other peers that have a rating on ALNY. Out of the 3 peers that are also analyzing ALNY, 1 agrees with Christopher's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- David Lebovitz of "Morgan Stanley" Maintained at Hold with Increased Target to $50 on, Thursday, August 10th, 2017
These are the ratings of the 2 analyists that currently disagree with Christopher
- Do Kim of "BMO Capital" Maintained at Buy with Decreased Target to $99 on, Friday, September 8th, 2017
- Geoff Meacham of "Barclays" Initiated at Buy with Increased Target to $105 on, Thursday, September 7th, 2017
Similar Stocks and Investing Articles
[ Tue, Sep 12th 2017
] - WOPRAI
[ Mon, Sep 11th 2017
] - WOPRAI
[ Fri, Sep 08th 2017
] - WOPRAI
[ Wed, Mar 08th 2017
] - WOPRAI
[ Thu, Sep 08th 2016
] - WOPRAI
[ Thu, Sep 10th 2015
] - WOPRAI
[ Mon, Aug 31st 2015
] - WOPRAI
[ Wed, Nov 05th 2014
] - WOPRAI
[ Fri, Oct 10th 2014
] - WOPRAI